![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 43791 |
FusionGeneSummary for ZNF93_AP2A2 |
![]() |
Fusion gene information | Fusion gene name: ZNF93_AP2A2 | Fusion gene ID: 43791 | Hgene | Tgene | Gene symbol | ZNF93 | AP2A2 | Gene ID | 81931 | 161 |
Gene name | zinc finger protein 93 | adaptor related protein complex 2 subunit alpha 2 | |
Synonyms | HPF34|HTF34|TF34|ZNF505 | ADTAB|CLAPA2|HIP-9|HIP9|HYPJ | |
Cytomap | 19p12 | 11p15.5 | |
Type of gene | protein-coding | protein-coding | |
Description | zinc finger protein 93zinc finger protein 505zinc finger protein HTF34 | AP-2 complex subunit alpha-2100 kDa coated vesicle protein Cadapter-related protein complex 2 subunit alpha-2adaptin, alpha Badaptor related protein complex 2 alpha 2 subunitalpha-adaptin C; Huntingtin interacting protein Jalpha2-adaptinclathrin as | |
Modification date | 20180522 | 20180522 | |
UniProtAcc | P35789 | O94973 | |
Ensembl transtripts involved in fusion gene | ENST00000592613, ENST00000591366, ENST00000592160, ENST00000343769, | ENST00000534328, ENST00000332231, ENST00000448903, ENST00000525891, | |
Fusion gene scores | * DoF score | 2 X 2 X 2=8 | 4 X 4 X 3=48 |
# samples | 2 | 4 | |
** MAII score | log2(2/8*10)=1.32192809488736 | log2(4/48*10)=-0.263034405833794 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: ZNF93 [Title/Abstract] AND AP2A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | ZNF93 | GO:0045892 | negative regulation of transcription, DNA-templated | 25274305 |
Hgene | ZNF93 | GO:0070895 | negative regulation of transposon integration | 25274305 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | DB178459 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-intron | ENST00000592613 | ENST00000534328 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
3UTR-intron | ENST00000592613 | ENST00000332231 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
3UTR-intron | ENST00000592613 | ENST00000448903 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
3UTR-3UTR | ENST00000592613 | ENST00000525891 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000591366 | ENST00000534328 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000591366 | ENST00000332231 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000591366 | ENST00000448903 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-3UTR | ENST00000591366 | ENST00000525891 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000592160 | ENST00000534328 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000592160 | ENST00000332231 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000592160 | ENST00000448903 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-3UTR | ENST00000592160 | ENST00000525891 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000343769 | ENST00000534328 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000343769 | ENST00000332231 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-intron | ENST00000343769 | ENST00000448903 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
5CDS-3UTR | ENST00000343769 | ENST00000525891 | ZNF93 | chr19 | 20011902 | + | AP2A2 | chr11 | 1003721 | + |
Top |
FusionProtFeatures for ZNF93_AP2A2 |
![]() |
Hgene | Tgene |
ZNF93 | AP2A2 |
Transcription factor specifically required to represslong interspersed nuclear element 1 (L1) retrotransposons:recognizes and binds L1 sequences and repress their expression byrecruiting a repressive complex containing TRIM28/KAP1(PubMed:25274305). Not able to repress expression of all subtypesof L1 elements. Binds to the 5' end of L1PA4, L1PA5 and L1PA6subtypes, and some L1PA3 subtypes. Does not bind to L1PA7 or oldersubtypes nor at the most recently evolved L1PA2 and L1Hs. 50% ofL1PA3 elements have lost the ZNF93-binding site, explaining whyZNF93 is not able to repress their expression (PubMed:25274305).{ECO:0000269|PubMed:25274305}. | Component of the adaptor protein complex 2 (AP-2).Adaptor protein complexes function in protein transport viatransport vesicles in different membrane traffic pathways. Adaptorprotein complexes are vesicle coat components and appear to beinvolved in cargo selection and vesicle formation. AP-2 isinvolved in clathrin-dependent endocytosis in which cargo proteinsare incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with theearly endosome. The clathrin lattice serves as a mechanicalscaffold but is itself unable to bind directly to membranecomponents. Clathrin-associated adaptor protein (AP) complexeswhich can bind directly to both the clathrin lattice and to thelipid and protein components of membranes are considered to be themajor clathrin adaptors contributing the CCV formation. AP-2 alsoserves as a cargo receptor to selectively sort the membraneproteins involved in receptor-mediated endocytosis. AP-2 seems toplay a role in the recycling of synaptic vesicle membranes fromthe presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi)and [ED]-X-X-X-L-[LI] endocytosis signal motifs within thecytosolic tails of transmembrane cargo molecules. AP-2 may alsoplay a role in maintaining normal post-endocytic traffickingthrough the ARF6-regulated, non-clathrin pathway. The AP-2 alphasubunit binds polyphosphoinositide-containing lipids, positioningAP-2 on the membrane. The AP-2 alpha subunit acts via its C-terminal appendage domain as a scaffolding platform for endocyticaccessory proteins. The AP-2 alpha and AP-2 sigma subunits arethought to contribute to the recognition of the [ED]-X-X-X-L-[LI]motif (By similarity). {ECO:0000250, ECO:0000269|PubMed:12960147,ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:15473838,ECO:0000269|PubMed:19033387}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZNF93_AP2A2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZNF93_AP2A2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
ZNF93 | FBL | AP2A2 | HTT, DAB2, EPS15, SHC1, AMPH, CLTC, EPN1, TERF2, ARRB2, BIN1, GRB2, GRK5, AP2M1, APP, AP2A1, VCP, FN1, SMAD1, PAN2, EGFR, PPP6R3, RPA3, RPA2, RPA1, PIP5K1C, ATP1A1, MOV10, NXF1, NECAP2, LRFN4, AAGAB, ZBTB46, NTRK1, AP1B1, AP2S1, NAPA, NUTF2, AP2B1, EIF2B1, CLTB, DBN1, GAK, KIF11, IQGAP1, FAN1, LIMA1, GTSE1, YBX1, MCM2, ESR1, MEX3C, RNF126, NLGN3, DIEXF, MYO6, MTMR4, RUNDC3A, ARFGAP1, SNX9, GPBP1L1, GPR156, CLINT1, FCHO1, REPS1, LSR, CPSF4L, INTS4, UBC, OCRL, SLC2A8 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZNF93_AP2A2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ZNF93_AP2A2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |